Stay updated with breaking news from Complex Concentrates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Demand for prothrombin complex concentrates market is expected to reach US$ 772.0 million in 2023 and US$ 1.2 billion in 2033. As the market for prothrombin complex concentrates is expected to grow at a steady CAGR of 4.1%, the United Kingdom, the United States, China, and India are expected to emerge as major produ...
Share this article Share this article ALBANY, N.Y, Jan. 28, 2021 /PRNewswire/ --Â Anticoagulant reversal drugs are widely used to reverse the anticoagulation effect in specific scenarios including overdose of anticoagulant therapy, uncontrolled bleeding, and unplanned surgery. Vitamin K, prothrombin complex concentrates, tranexamic acid, protamine, AndeXXa, and idarucizumab are some of the products available in the global anticoagulant reversal drugs market. Researchers at TMR are of the opinion that the global anticoagulant reversal drugs market will show growth at a whopping CAGR of 15.6% d...